BioSpace News Archive

Business

Delix Therapeutics Announces Appointment of Dr. John Krystal to Scientific & Strategic Advisory Board

Delix Therapeutics today announced the appointment of Dr. John Krystal, a leading expert in the study and treatment of alcohol use disorder, post-traumatic stress disorder (PTSD), schizophrenia, and depression, to its Scientific and Strategic Advisory Board.

October 25, 2021
·
4 min read
Antengene to Host its First R&D Days on November 16 and November 18, 2021

Virtual Event (in English) on November 16 On Site Event with Live Webcast (in Mandarin) on Nov 18

October 25, 2021
·
2 min read
Lone Star Bio

Pandemic-Driven Changes in Pharma Here to Stay as New Clinical Trial Models Take Hold

COVID-19 physical distancing requirements forced change in how traditional clinical trials were conducted and a new Informa Pharma and Oracle study shows the industry is not looking back.

October 25, 2021
·
4 min read
Business

Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 2021

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced the results of two key retrospective analyses at the American College of Gastroenterology 2021 annual congress.

October 25, 2021
·
10 min read
Business

Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer

Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with KEYTRUDA ® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer

October 25, 2021
·
8 min read
Business

Altoida and Ionian University Investigate Breakthrough Software Device for Parkinson’s Disease Diagnosis

Altoida, Inc. the world’s leading Precision Neurology company, announced a collaboration with the Bioinformatics and Human Electrophysiology Laboratory (BiHELab), Department of Informatics at Ionian University.

October 25, 2021
·
3 min read
Business

Marinus Pharmaceuticals Joins the Loulou Foundation in Collaboration on CANDID, a Comprehensive Observational Study in CDKL5 Deficiency Disorder

Marinus Pharmaceuticals, Inc . today announced it has joined forces with the Loulou Foundation and six other biotech and pharmaceutical organizations, to undertake a key observational CDD clinical study to better understand the natural history and the utility of various clinical assessments.

October 25, 2021
·
7 min read
Biotech Beach

Exagen Inc. Announces $27.2 Million Debt Refinancing

Exagen Inc. announced today that it entered into an amendment to its loan and security agreement with its primary lender, an affiliate of Innovatus Capital Partners, LLC (“Innovatus”).

October 25, 2021
·
4 min read
Pharm Country

Akari Therapeutics Announces New Data with Nomacopan from its Surface of the Eye Program

Akari Therapeutics, Plc today announces data highlighting the potential of nomacopan in the surface of the eye in Allergy, European Journal of Allergy and Clinical Immunology.

October 25, 2021
·
7 min read
Business

Genetic Technologies Reports Q1 FY22 ResultsGenetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious disease provides its results for its first quarter of fiscal year 2022, ended September 30, 2021.

October 25, 2021
·
10 min read